Caitlin Elgarten, MD

female silhouette icon
Caitlin Elgarten, MD, is an attending physician with the Cancer Center at Children's Hospital of Philadelphia.

Locations: Main Hospital

Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467)

Education and Training


Pediatrics - The Children's Hospital of Philadelphia, Philadelphia, PA


Pediatrics - The Children's Hospital of Philadelphia, Philadelphia, PA


Pediatric Hematology/Oncology - The Children's Hospital of Philadelphia, Philadelphia, PA

Board Certification

Pediatrics – American Board of Pediatrics

Graduate Degree

MD - Columbia University, New York, NY

Titles and Academic Titles

Attending Physician

Assistant Professor, Perelman School of Medicine at the University of Pennsylvania

Departments and Services




Elgarten CW, Levy EM, Mattei P, Fisher BT, Olson TS, Freedman JL.: Successful treatment of Pulmonary Mucormycosis in Two Pediatric Hematopoietic Cell Transplant Patients. Pediatric Blood and Cancer 2018.

Elgarten CW, Arnold SD, Li Y, Huang Y-S, Riches M, Gerber JS, Aplenc R, Saber W, Fisher BT.: Hospital-level variability in broad-spectrum antibiotic use for children with acute leukemia undergoing hematopoietic cell transplantation.  Infection Control and Hospital Epidemiology 2018.

Elgarten CW, Arnold DE, Bunin NJ, Seif AE. : Outcomes of matched sibling donor bone marrow transplantation in children using single-agent calcineurin inhibitors as prophylaxis for graft versus host disease.  Pediatric Blood Cancer 2018.

Cahen, VC, Li Y, Elgarten CW, DiNofia AM, Wilkes JJ, Winestone LE, Huang Y-S, Fitzgeral JC, Gramatges MM, Rabin KR, Fisher BT, Getz KD, Aplenc R, Seif AE. : Validation of approaches using administrative data to identify relapse and hematopoietic stem cell transplantation in children with acute lymphoblastic leukemia.  Pharmacoepidemiology and Drug Safety 2018.



Seif AE, Cahen VC, Li Y, Elgarten CW, Dinofia A, Wilkes J, Winestone L, Huang Y-S,Fitzgerald J, Fisher BT, Reid G, Getz K, Aplenc R.: Severe Sepsis As Immune Stimulation and Protection from Relapse of Childhood Acute Lymphoblastic Leukemia(ALL): Results from a Pilot Study and Validation of Events in a National Administrative Dataset. ASH Annual Meeting, Atlanta GA, December 2017.   ASH Annual Meeting, Atlanta GA 2017.

Elgarten CW, Arnold S, Li Y, Huang Y-S, Gerber J, Saber W, Aplenc R, Fisher B.: Center-level variability in broad-spectrum antibiotic prescribing for children undergoing hematopoietic cell transplantation for acute leukemia.  IDWeek 2017, San Diego, CA October  2017.

Posters and Presentations

Invited Lectures


Elgarten CW. "Gabapentin as an antiemetic" - Children's Oncology Group, Cancer Control and Supportive Care Committee, Webinar. Sep, 2017.

Elgarten CW. "Study Proposal 1611-113: Investigating antibiotic exposure and risk of GVHD in pediatric patients undergoing HSCT for acute leukemia" - BMT Tandem Meetings, Orlando, Florida. Feb, 2017.

Awards and Honors

2010, Paul H. Douglas Fellowship for outstanding work in HIV/AIDS
2010, American Medical Association Seed Grant
2009, Doris Duke Fellowship for Clinical Research

Editorial and Academic Positions

Editorial Positions

2017-present, Reviewer, Pediatric Blood and Cancer
2016-present, Fellow Editor, Pharmacoepidemiology and Drug Safety

Leadership and Memberships

Memberships in Professional Organizations


2015-present, Children's Oncology Group


2017-present, American College of Epidemiology
2016-present, American Society of Pediatric Hematology/Oncology
2016-present, American Society of Hematology
2016-present, American Society of Clinical Oncologists
2016-present, American Society for Blood and Marrow Transplantation